急性髓性白血病的分子特征和治疗范式
Mihir Shukla1, Maher Abdul-Hay1, Jun H Choi1
1Department of Hematology and Medical Oncology, NYU Langone Health, Perlmutter Cancer Center, New York, NY 10016, USA.
急性髓性白血病 (AML) 是一个衰老的疾病. 下一代测序的进步使得针对AML的向治疗成为可能,专注于个性化医学的分子改变.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 急性髓性白血病 (AML) 是一种流行的血液性恶性瘤,主要影响老年人.
- 传统的治疗方法,如化疗和干细胞移植有局限性,特别是在老年患者.
- 分子洞察对于完善AML分类,风险分层和预后至关重要.
研究的目的:
- 审查AML中的关键分子变化和染色体变化.
- 讨论这些遗传变化的病理生理学.
- 概述目前和新兴的治疗策略,针对AML中的分子异常.
主要方法:
- 关于AML分子生物学近期进展的文献综述.
- 分析下一代测序数据及其对治疗的影响.
- 综合有关基因特异性疗法和正在进行的临床试验的信息.
主要成果:
- 下一代测序已经促进了针对AML的向分子疗法的采用.
- 像FLT3和IDH1/2这样的特定突变已经建立了基因特异性治疗方法.
- 许多AML突变正在研究中,治疗研究处于临床前阶段.
结论:
- 在AML治疗中,分子向越来越重要,特别是在老年患者中.
- 了解基因水平的变化对于AML个性化医疗方法至关重要.
- 进一步研究AML病理生理学和新的治疗点是必不可少的.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
